We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
-14.02%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$8.88B
AUM Growth
-$1.57B
Cap. Flow
+$103M
Cap. Flow %
1.15%
Top 10 Hldgs %
15.32%
Holding
763
New
20
Increased
297
Reduced
294
Closed
39

Top Buys

Rank Stock Value
1
UL icon
Unilever
UL
+$28M
2
PRGO icon
Perrigo
PRGO
+$25.4M
3
J icon
Jacobs Solutions
J
+$23.4M
4
ICUI icon
ICU Medical
ICUI
+$21.3M
5
SSB icon
SouthState Bank Corp
SSB
+$20.1M

Sector Composition

Rank Sector Weight
1 Technology 19.41%
2 Healthcare 18.06%
3 Industrials 15.07%
4 Financials 12.92%
5 Consumer Discretionary 8.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPT icon
176
Sprout Social
SPT
$530M
$12M 0.14%
207,385
+61,538
+42% +$3.58M
CTAS icon
177
Cintas
CTAS
$86.6B
$12M 0.14%
128,604
-7,124
-5% -$694K
BECN
178
DELISTED
Beacon Roofing Supply, Inc.
BECN
$11.9M 0.13%
232,082
-231,688
-50% -$13.6M
PGR icon
179
Progressive
PGR
$128B
$11.9M 0.13%
102,180
-1,036
-1% -$117K
FOXF icon
180
Fox Factory Holding Corp
FOXF
$794M
$11.7M 0.13%
144,845
+25,663
+22% +$2.16M
MEDP icon
181
Medpace
MEDP
$16.3B
$11.3M 0.13%
75,622
+9,733
+15% +$1.41M
IART icon
182
Integra LifeSciences
IART
$1.28B
$11.1M 0.13%
206,365
+47,391
+30% +$2.85M
THC icon
183
Tenet Healthcare
THC
$22.2B
$11.1M 0.13%
211,760
+43,665
+26% +$3.04M
CMCO icon
184
Columbus McKinnon
CMCO
$422M
$11M 0.12%
388,738
+4,591
+1% +$158K
HZNP
185
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$11M 0.12%
137,621
-25,094
-15% -$2.38M
KO icon
186
Coca-Cola
KO
$383B
$10.8M 0.12%
171,224
+2,035
+1% +$129K
MTRN icon
187
Materion
MTRN
$3.94B
$10.7M 0.12%
145,470
+38,986
+37% +$3.13M
SRDX
188
DELISTED
Surmodics
SRDX
$10.7M 0.12%
286,639
+3,428
+1% +$133K
DG icon
189
Dollar General
DG
$28.4B
$10.6M 0.12%
43,317
-428
-1% -$99.9K
QUOT
190
DELISTED
Quotient Technology Inc
QUOT
$10.6M 0.12%
3,572,434
+329,755
+10% +$1.56M
WAL icon
191
Western Alliance Bancorporation
WAL
$8.81B
$10.6M 0.12%
150,030
-457,143
-75% -$35M
ORCL icon
192
Oracle
ORCL
$339B
$10.6M 0.12%
151,337
-1,181
-0.8% -$86.5K
EHTH icon
193
eHealth
EHTH
$41.9M
$10.5M 0.12%
1,128,159
+17,481
+2% +$178K
OPCH icon
194
Option Care Health
OPCH
$3.76B
$10.4M 0.12%
375,295
+111,322
+42% +$3.17M
POWI icon
195
Power Integrations
POWI
$3.15B
$10.4M 0.12%
139,040
+41,340
+42% +$3.35M
SHW icon
196
Sherwin-Williams
SHW
$84.8B
$10.3M 0.12%
46,121
-1
-0% -$257
BPMC
197
DELISTED
Blueprint Medicines
BPMC
$10.3M 0.12%
204,188
+28,752
+16% +$1.68M
TXRH icon
198
Texas Roadhouse
TXRH
$13.7B
$10.3M 0.12%
+140,502
New +$11M
LKQ icon
199
LKQ Corp
LKQ
$6.72B
$10.3M 0.12%
208,913
-13,617
-6% -$671K
LOW icon
200
Lowe's Companies
LOW
$121B
$10.2M 0.12%
58,520
-2,493
-4% -$481K

Similar funds

Segall Bryant & Hamill's Q2 2022 Portfolio in Review

As of Q2 2022, Segall Bryant & Hamill held 763 positions worth $8.88B, down 15% from $10.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Segall Bryant & Hamill's Q2 2022 filing shows 20 new, 297 increased, 294 reduced and 39 closed positions. Its largest new stake was Perrigo: 684,450 shares worth $27.7M. The largest sale was Western Alliance Bancorporation, an estimated $35M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Healthcare and Industrials.

  • Segall Bryant & Hamill's largest Q2 2022 buy was Perrigo: 684,450 shares worth $27.7M.
  • Segall Bryant & Hamill added most to Unilever in Q2 2022, an estimated $28M increase.
  • Segall Bryant & Hamill's biggest Q2 2022 reduction was Western Alliance Bancorporation, cutting an estimated $35M.
  • Segall Bryant & Hamill fully exited Anaplan, Inc. in Q2 2022, selling an estimated $22.7M.
  • Segall Bryant & Hamill's ten largest holdings make up 15% of its $8.88B portfolio in Q2 2022.
  • Segall Bryant & Hamill opened 20 new positions and closed 39 in Q2 2022.
  • Segall Bryant & Hamill's portfolio value fell 15% quarter-over-quarter to $8.88B.

Based on Segall Bryant & Hamill's 13F filing for Q2 2022, filed 15 Aug 2022.